版本:
中国

BRIEF-Ra Pharmaceuticals initiates dosing of RA101495 in PNH patients

April 26 Ra Pharmaceuticals Inc

* Ra Pharmaceuticals initiates dosing of ra101495 in PNH patients

* Ra Pharmaceuticals Inc says initial data from global phase 2 program expected mid-2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐